PURPOSE: There is conflicting data on the relationship between anemia and outcomes in patients with traumatic brain injuries (TBI). The objective of this study was to determine if the proportion of time and area under the hemoglobin-time curve of ≥90 g/L are independently associated with 6-month functional outcomes. METHODS: Retrospective cohort study of 116 patients with a severe TBI who underwent invasive neuromonitoring between June 2006 and December 2013. Hemoglobin area (HAI) and time (HTI) indices were calculated by dividing the total area, or time, under the hemoglobin-time curve at 90 g/L or above by the total duration of monitoring. Multivariable log-binomial regression was used to model the association between HAI or HTI and 6 month favorable neurologic outcome (Glasgow Outcome Score 4 or 5). RESULTS: Patients had a mean age of 38 years (SD 16) with a median admission Glasgow Coma Scale of 6 (IQR 4-7). There were 1523 hemoglobin measurements and 523 monitoring days. Patients had a hemoglobin ≥90 g/L for a median of 70 % (IQR 37-100) of the time. Each 10 g/L increase in HAI (RR 1.23, 95 %CI 1.04-1.44, P = 0.011), and 10 % increase in HTI (1.10, 95 %CI 1.04-1.16, P < 0.001) were associated with improved neurologic outcome. Thirty-one patients (27 %) received a transfusion with the median pre-transfusion hemoglobin being 81 g/L (IQR 76-87). CONCLUSIONS: In patients with severe TBI, increased area under the curve and percentage of time that the hemoglobin concentration was ≥90 g/L, were associated with improved neurologic outcomes.
PURPOSE: There is conflicting data on the relationship between anemia and outcomes in patients with traumatic brain injuries (TBI). The objective of this study was to determine if the proportion of time and area under the hemoglobin-time curve of ≥90 g/L are independently associated with 6-month functional outcomes. METHODS: Retrospective cohort study of 116 patients with a severe TBI who underwent invasive neuromonitoring between June 2006 and December 2013. Hemoglobin area (HAI) and time (HTI) indices were calculated by dividing the total area, or time, under the hemoglobin-time curve at 90 g/L or above by the total duration of monitoring. Multivariable log-binomial regression was used to model the association between HAI or HTI and 6 month favorable neurologic outcome (Glasgow Outcome Score 4 or 5). RESULTS:Patients had a mean age of 38 years (SD 16) with a median admission Glasgow Coma Scale of 6 (IQR 4-7). There were 1523 hemoglobin measurements and 523 monitoring days. Patients had a hemoglobin ≥90 g/L for a median of 70 % (IQR 37-100) of the time. Each 10 g/L increase in HAI (RR 1.23, 95 %CI 1.04-1.44, P = 0.011), and 10 % increase in HTI (1.10, 95 %CI 1.04-1.16, P < 0.001) were associated with improved neurologic outcome. Thirty-one patients (27 %) received a transfusion with the median pre-transfusion hemoglobin being 81 g/L (IQR 76-87). CONCLUSIONS: In patients with severe TBI, increased area under the curve and percentage of time that the hemoglobin concentration was ≥90 g/L, were associated with improved neurologic outcomes.
Authors: Mypinder S Sekhon; Vinay K Dhingra; Indeep S Sekhon; William R Henderson; Neilson McLean; Donald E G Griesdale Journal: J Crit Care Date: 2011-01-26 Impact factor: 3.425
Authors: Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger Journal: Epidemiology Date: 2007-11 Impact factor: 4.822
Authors: Matthew A Warner; Terence O'Keeffe; Premal Bhavsar; Rashmi Shringer; Carol Moore; Caryn Harper; Christopher J Madden; Ravi Sarode; Larry M Gentilello; Ramon Diaz-Arrastia Journal: J Neurosurg Date: 2010-09 Impact factor: 5.115
Authors: Lena M Napolitano; Stanley Kurek; Fred A Luchette; Howard L Corwin; Philip S Barie; Samuel A Tisherman; Paul C Hebert; Gary L Anderson; Michael R Bard; William Bromberg; William C Chiu; Mark D Cipolle; Keith D Clancy; Lawrence Diebel; William S Hoff; K Michael Hughes; Imtiaz Munshi; Donna Nayduch; Rovinder Sandhu; Jay A Yelon Journal: Crit Care Med Date: 2009-12 Impact factor: 7.598
Authors: Gregory M T Hare; C David Mazer; James S Hutchison; Anya T McLaren; Elaine Liu; Alipasha Rassouli; Jinglu Ai; Rachel E Shaye; Julia A Lockwood; Cynthia E Hawkins; Nancy Sikich; Kevin To; Andrew J Baker Journal: J Appl Physiol (1985) Date: 2007-06-07
Authors: Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro Journal: Crit Care Med Date: 2004-01 Impact factor: 7.598
Authors: Robert W Taylor; Lisa Manganaro; Jacklyn O'Brien; Steven J Trottier; Nadeem Parkar; Christopher Veremakis Journal: Crit Care Med Date: 2002-10 Impact factor: 7.598